Pictet Asset Management Holding Sa Travere Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 709,390 shares of TVTX stock, worth $16.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
709,390
Previous 762,908
7.02%
Holding current value
$16.7 Million
Previous $10.7 Million
15.78%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding TVTX
# of Institutions
213Shares Held
94.1MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$180 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$174 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$159 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$117 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$100 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.51B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...